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Abstract  12 
Conventional dendritic cells (cDC) are professional antigen-presenting cells 13 
that induce immune activation or tolerance. Two functionally specialised 14 
populations, termed cDC1 and cDC2, have been described in humans, mice, 15 
ruminants and recently in pigs. Pigs are an important biomedical model 16 
species and a key source of animal protein; therefore further understanding of 17 
their immune system will help underpin the development of disease 18 
prevention strategies. To characterise cDC populations in porcine blood, DC 19 
were enriched from PBMC by CD14 depletion and CD172a enrichment then 20 
stained with a lineage mAbs (Lin; CD3, CD8α, CD14 and CD21) and mAbs 21 
specific for CD172a, CD1 and CD4. Two distinct porcine cDC subpopulations 22 
were FACSorted CD1- cDC (Lin-CD172+CD1-CD4-) and CD1+ cDC (Lin-23 
CD172a+CD1+CD4-), and characterised by phenotypic and functional 24 
analyses. CD1+ cDC were distinct from CD1- cDC, expressing higher levels of 25 
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CD172a, MHC class II and CD11b. Following TLR stimulation, CD1+ cDC 26 
produced IL-8 and IL-10 while CD1- cDC secreted IFN-α, IL-12 and TNF-α. 27 
CD1- cDC were superior in stimulating allogeneic T cell responses and in 28 
cross-presenting viral antigens to CD8 T cells. Comparison of transcriptional 29 
profiles further suggested that the CD1- and CD1+ populations were enriched 30 
for the orthologues of cDC1 and cDC2 subsets respectively. 31 
 32 
Introduction 33 
Dendritic cells (DC) were first identified in the peripheral lymphoid organs of 34 
mice1 and are regarded as the sentinels of the immune system. Often resident 35 
in tissues close to sites of pathogen entry, DC take up antigen and migrate to 36 
lymphoid organs where they present antigen to T cells 2. DC are unique in 37 
their capacity to activate naïve T cells 3 but also play a pivotal role in 38 
maintaining central tolerance to self-antigen 4. DC can be broadly classified 39 
into two lineage populations; plasmacytoid DC (pDC), specialising in 40 
production of cytokines, most notably type I IFNs 5 and conventional DC 41 
(cDC), which are potent antigen-presenting cells (APCs) 6. In the mouse, 42 
splenic cDC populations were further delineated based on expression of 43 
CD8α and CD11b (CD8α+CD11b- and CD8α-CD11b+)7.  CD8α+ cDC express 44 
XCR1, TLR38, produce IL-129,10 and are highly efficient at cross-presenting 45 
exogenous antigen to CD8+ T cells11-13. They are specialised in the uptake of 46 
apoptotic bodies 13 and are generally located in the T cell areas of the Peyer’s 47 
patches and the spleen14. Mice lacking XCR1 or its ligand, are less able to 48 
cross-present antigen necessary for induction of CD8+ T cell responses 49 
against various viruses and bacteria.7 15 . In contrast, the CD11b+ subset of 50 
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cDC are located in areas associated with antigen uptake, including the 51 
marginal zone and sub-epithelial dome of secondary lymphoid tissues, and 52 
show high rates of endocytosis and phagocytosis 16.  CD11b+ DC also 53 
express high levels of proteins involved in MHC class II presentation and are 54 
most efficient at inducing CD4+ Th2 responses, whereas Th1 responses are 55 
preferentially induced by CD8α+ cDC 9,17,18. 56 
The CD8α+CD11b- and CD8α-CD11b+ populations have now been classified 57 
as cDC1 and cDC2 respectively with a conserved phenotype and function 58 
seen across several mammalian species19.  For example, the human CD141+ 59 
cDC subset in blood is equivalent to the mouse cDC1, sharing expression of 60 
CLEC9a 20-22, XCR1 22,23, CADM1, TLR3, BAFT3 and IRF8 24,25. These cells 61 
also produce type III IFN 26 following activation with a TLR3 agonist.  62 
However, unlike the mouse the unique capacity for effective cross-63 
presentation by the human cDC1 subset is more controversial 27,28; while 64 
some studies have demonstrated that cDC1 DCs are superior 22,23,29, others 65 
have concluded that tonsillar cDC1 possess a comparable capacity to cDC2  66 
30. Others have shown that TLR3 stimulation is necessary for blood-derived 67 
cDC1 to efficiently cross-present, but was not required for skin derived 68 
cDC131. Certainly the precise conditions, such as the source of cDC and the 69 
nature of the antigen, are likely to play a role in influencing cross-presentation, 70 
in humans and possibly other mammalian species. In comparison, human 71 
CD1c+ cDC2 express higher levels of mRNA associated with MHC class II 72 
antigen processing including up-regulation of cathepsin H29.  A comparative 73 
analysis of the transcriptomes of human and murine cDC subsets has shown 74 
marked similarity between murine splenic CD11b+ and CD8α+ cDC and 75 
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human blood CD1c+ and CD141+ cDC, respectively 24,32.  Transcriptional and 76 
functional profiling has further demonstrated that the two major cDC 77 
populations are also conserved in sheep 33 and macaques34. Ovine efferent 78 
lymph CD26+CD172a- cDC share properties with cDC1, including expression 79 
of transcription factors ID2, IRF8, BATF3, the membrane proteins CLEC9a 80 
and CADM1, IL-12, and were superior to CD26-CD172a+ cDC in their ability to 81 
activate antigen-specific CD8 T cells 33.      82 
The pig represents an economically significant livestock species and an 83 
important large animal model for biomedical research in fields such as 84 
xenotransplantation and influenza infection biology.  With the intention of 85 
identifying cDC in the skin as targets for vaccination strategies others have 86 
demonstrated that porcine skin CD163low cells share phenotypic and 87 
transcriptomic features consistent with the cDC2, and a CD172a- subset 88 
orthologous to cDC1 cells 35,36.  Similar populations have also recently been 89 
identified in the lung37.  In addition to providing new avenues for DC-targeted 90 
vaccine approaches, definition of the phenotype and function of cDC subsets 91 
in the pig will enable an improved understanding of the interaction of these 92 
cells with pathogens, including a number of globally economically important 93 
myelotropic viruses such as classical swine fever, African swine fever, and 94 
porcine reproductive and respiratory syndrome viruses. Blood represents an 95 
easily accessible tissue, enabling repeated sampling from live animals which 96 
supports the reduction in use of animals in scientific research. In porcine 97 
blood, cDC have been identified as possessing the lineage-CD172a+ 98 
phenotype 38-40 which are further delineated on the basis of CD4 expression 99 
into CD4+ pDC and CD4- cDC 38.  Given the expression of CD1 and CD11b on 100 
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a subpopulation of porcine cDC38,39, we hypothesised that this subset may be 101 
analogous to cDC2 and conversely that porcine CD1-CD11b- cDC might be 102 
enriched for the equivalent to cDC1. Through a combination of phenotypic and 103 
functional analysis as well as comparative transcriptomics we show here that 104 
the porcine blood CD1+ cDC population is orthologous to cDC2 cells 105 
described in other mammals. The CD1- cDC subset, contains both XCR1hi 106 
cells previously described in other mammals as cDC1 cells, but also cDC 107 
expressing varying levels of CADM1 and XCR1 potentially representing 108 
variants of cDC1 DC at different stages of maturation or activation.   109 
 110 
 111 
Results 112 
Sorting and phenotypic characterisation of porcine blood dendritic cells 113 
CD172a (SIRP-α) is expressed on porcine DC circulating in blood38,40.  114 
Monocytes circulate at significantly higher numbers than DC in the blood and 115 
also express CD172a albeit at a higher level than observed on the surface of 116 
DC 41. To permit the successful enrichment of highly pure populations of blood 117 
DC, PBMC were first depleted of monocytes using the monocyte specific 118 
marker CD14 42,43 and the resulting CD14 negative fraction enriched for 119 
CD172a+ cells using magnetic-based cell sorting (Figure 1A). The resulting 120 
CD14-CD172a+ enriched DC population was stained with fluorochrome-121 
labelled antibodies to CD172a, lineage markers (CD3, CD8α, CD14, CD21), 122 
CD1 and CD4 prior to flow cytometric cell sorting (Figure 1B). Blood DC were 123 
firstly identified as CD172a+lin- cells, and CD172ahigh cells were excluded 124 
since it has been shown that Tuk4 antibody for CD14 may not identify all 125 
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monocytes 44,45.  Two populations of CD172a+lin- cells could be identified; 126 
CD4-CD1- and CD4-CD1+; while pDC were identified as CD4+CD1- cells 127 
(Figure 1A) as previously reported38. After sorting, the purity of the three 128 
populations was assessed both for contamination by lymphocytes and other 129 
DC subsets by flow cytometric analysis and were typically >95% pure (Figure 130 
1B). Notably, we observed that the cDC express different levels of CD172a 131 
(Figure 1B). Staining these populations directly in intact PBMC (i.e. non-CD14 132 
depleted and non-CD172a enriched PBMC) showed that these cells circulate 133 
at approximately 0.5-1% (pDC), 0.1% (CD1+ cDC) and 0.1% (CD1- cDC) of 134 
the total PBMC population (Supplementary Figure S1).  135 
To further delineate the 3 populations of freshly sorted blood DC, cells 136 
were stained with a panel of antibodies directed to markers known to be 137 
expressed on porcine monocyte-derived DC 46 and DC in human blood 47 138 
(Figure 2). Purified monocytes were included for comparison. Since the 139 
individual cell populations varied in both their levels of autofluorescence and 140 
spill-over fluorescence associated with the specific antibodies employed for 141 
sorting, staining with isotype control antibodies was used to normalise the 142 
results across the four cell populations and confine the negative controls to 143 
the first log decade. MHC class II (MHC-II)  expression by monocytes showed 144 
a biphasic profile, most likely representing mature and immature populations 145 
of monocytes previously described in pig with differing levels of MHC-II 42.  In 146 
contrast, each blood DC population showed relatively uniform expression of 147 
MHC-II suggesting isolation of homogenous populations.  Freshly isolated 148 
pDC expressed very low levels of MHC-II as has been previously described38.  149 
CD11R3, believed to be the orthologue of human CD11b, was expressed at 150 
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high levels on monocytes, as shown previously in pigs 43 and humans 151 
(CD11b) 48 and also on CD1+ cDC.  There was no expression on CD1- cDC 152 
and pDC. Differential levels of CD16 expression were also observed; CD1+ 153 
cDC lacked CD16 expression and pDC expressed very little, while slightly 154 
higher levels were observed on some CD1- cDC. All freshly isolated 155 
populations lacked expression of CD83 and the co-stimulatory complex 156 
CD80/86, as assessed by staining with a CTLA-4 fusion protein.  157 
To determine if the isolated cDC populations gained an antigen 158 
presenting phenotype upon culture, DC were stained for MHC-II DR and 159 
CD80/86 following 18 h culture in the presence of IL-3 at 37oC, 5% CO2  160 
(Figure 3). Both CD1- and CD1+ cDC showed extremely high levels of MHC-II 161 
expression, and gained significant expression of CD80/86 on their surface, 162 
upon culture. Culture of monocytes induced only a modest up-regulation of 163 
MHC-II expression while both markers remained unchanged on cultured pDC.  164 
 165 
Cytokine responses to stimulation with pathogen-associated molecular 166 
patterns (PAMPs)  167 
DC express a broad repertoire of toll-like receptors (TLR) which 168 
recognise pathogen-associated molecular patterns (PAMPs) which serve to 169 
activate the DC, resulting in maturation and release of cytokines which 170 
polarise T cell differentiation 49. However, expression of TLRs is not uniform 171 
across DC subsets8, suggesting functional specificity towards various 172 
pathogens8.   For instance, TLR3 is expressed at the highest levels on CD8α+ 173 
cDC in mice 8 and CD141+ cDC in humans 29, 50 while TLR4 expression is 174 
restricted to BDCA-1+ cDC 29. To assess responses to PAMP stimulation 175 
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amongst the porcine DC populations, we stimulated sorted blood DC with 176 
three prototypic PAMPs; LPS (recognised by TLR4), poly (I:C) (recognised by 177 
TLR3 and also by cytosolic RNA helicases retinoic acid-inducible protein I 178 
(RIG-I) and melanoma differentiation-associate gene 5 (MDA-5) and Class B 179 
CpG-ODN 2007 (recognised by TLR9) and compared their cytokine secretion 180 
profiles across the three pig DC populations (Figure 4).  CD1- cDC responded 181 
to poly(I:C) and CpG-ODN, but not LPS, with secretion of IL-12, IFN-γ and 182 
IFN-α, although only the data for IFN-γ (CpG-ODN, p<0.05) and IFN-α (poly 183 
I:C p<0.0001, CpG-ODN p<0.0001) were statistically significant compared 184 
with unstimulated cells (probably caused by the inter-animal variability in the 185 
cytokine levels). In contrast, CD1+ cDC responded to LPS (p<0.0001) and 186 
poly(I:C) (p<0.01) with secretion of IL-10, and to LPS and CpG-ODN with IL-8. 187 
The pDC responded exclusively to poly(I:C) and CpG-ODN, with high levels of 188 
TNF-α (poly I:C, p<0.01, CpG-ODN, p<0.0001) IL-12 (poly I:C, p<0.0001, 189 
CpG-ODN, p<0.001), IFN-α (poly I:C, p<0.0001, CpG-ODN, p<0.0001), and 190 
IFN-γ (poly I:C, p<0.0001, CpG-ODN, p<0.0001).  In comparison, monocytes 191 
responded to LPS with high levels of TNFα (p<0.0001) and IFN-γ (p<0.001). 192 
They also secreted IL-10 and IL-8 in response to LPS (p<0.001) and CpG 193 
(p<0.01). 194 
  195 
Assessment of antigen uptake, processing and presentation by porcine blood 196 
DCs  197 
To gain further insight into the functional specialisation of the isolated 198 
DC populations, we compared the capacity of the cells to take up antigen, 199 
delivered either as soluble Alexa Fluor-647®-conjugated ovalbumin (OVA-200 
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AF647) or OVA-AF647 encapsulated in PLGA nanoparticles (Figure 5A). Both 201 
cDC populations took up greater amounts of soluble OVA-AF647 levels 202 
compared with pDC (p<0.001). However, CD1+ cDC were superior in their 203 
ability to take up soluble OVA-AF647 compared with CD1- cDC (p<0.001). In 204 
contrast, there was no difference in the ability of DC populations to take up 205 
particulate antigen, which was most efficiently endocytosed by monocytes.  206 
Murine CD8+ cDC,13,51 ovine CD26+ cDC 33 and human CD141+ cDC 207 
21,23,29 all have a superior capacity for cross-presenting exogenous antigen to 208 
CD8 T cells, which probably reflects their specialisation in the induction of 209 
immunity against intracellular pathogens. To determine whether the porcine 210 
blood CD1- cDC population shares this property, DC populations from two 211 
PRRSV-immune pigs were sorted, pulsed with either a synthetic peptide 212 
bearing previously identified CD4 and CD8 epitopes 52 or inactivated PRRSV, 213 
and the stimulation of IFN-γ responses from autologous CD4 and CD8 T cells 214 
was assessed by flow cytometry (Figure 5B and Supplementary Figure S2).  215 
Using the synthetic peptide, we observed that both cDC populations were 216 
more effective at stimulating CD4 T cell IFN-γ responses compared with pDC 217 
(p<0.05); a similar trend was observed for CD8 T cells, although without 218 
statistical significance.  Notably, there was no significant difference between 219 
the stimulatory properties of the two cDC populations for either T cell 220 
population (Figure 5B). However, when cultured with inactivated virus, the 221 
CD1- cDC showed a significant increase in their capacity to stimulate CD8 T 222 
cells compared with CD1+ cDC and pDC (p<0.05). Although there was no 223 
significant difference between the cDC populations in their ability to stimulate 224 
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virus-specific CD4 IFN-γ responses, CD1- cDC were superior to both pDC and 225 
monocytes.   226 
Finally, we compared the ability of porcine blood DC populations to 227 
stimulate primary allogeneic T cell responses using an MLR. In humans, 228 
CD1c+ cDC stimulate the strongest allogeneic MLR responses53, while others 229 
have demonstrated an equal ability in murine liver-derived cDC populations54. 230 
We found that CD1- cDC induced significantly stronger proliferation of 231 
allogeneic T cells than CD1+ cDCs, pDCs and monocytes at 1:2, 1:6 and 1:18 232 
(p<0.0001) and 1:54 (p<0.01) stimulator:responder cell ratios.  CD1+ cDCs 233 
were also better at stimulating allogeneic T cells than monocytes and pDCs at 234 
a 1:2 ratio (p<0.0001) and also at a 1:6 ratio compared to pDCs only (p<0.01) 235 
(Figure 5C). Interestingly, pDC showed very limited ability to stimulate 236 
allogeneic T cell proliferation.   237 
 238 
Porcine blood cDC populations show distinct gene expression signatures  239 
The data above show that the two porcine blood cDC populations identified 240 
are phenotypically and functionally distinct, and share characteristics with the 241 
cDC1 or cDC2 populations defined in other mammalian species. However, 242 
due to limits in the availability of porcine reagents compared to other species 243 
such as humans and mice, only a limited number of markers could be studied 244 
at the protein level. To explore a broader range of DC markers, we compared 245 
the porcine DC populations at the transcriptome level. This also enabled us to 246 
determine if the DC populations share a common gene expression signature 247 
as has been recently described for other species24,33,50,55,56. Employing a 248 
custom made NimbleGen 12x135K porcine array spanning a total of 19,351 249 
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genes, we investigated the gene expression profile of the FACS sorted CD1-, 250 
CD1+ and pDC dendritic cell populations from three separate pigs and 251 
compared these with monocytes from the same pigs. Principle component 252 
analysis of the gene expression analysis of cell subsets showed a separation 253 
between CD14+ monocytes on the one hand with the three blood DC 254 
populations (pDC, CD1- cDC and CD1+ cDC) on the other hand, along the first 255 
axis representing the major source (42%) of variability within the dataset 256 
(Figure 6). This supported that the CD1+ cells which we isolated are closer to 257 
FLT3-L-dependent DC than to monocytes. Moreover, on the second axis, still 258 
representing 23% of the variability of the dataset, porcine CD1- and CD1+ cDC 259 
were very close and clearly separated from both CD14+ monocytes and pDC. 260 
This near proximity supports the notion that these populations are highly 261 
enriched for cDC, being less similar to both monocyte and pDC. Three 262 
hundred and ninety six genes were significantly differentially expressed 263 
between CD1- and CD1+ DC, 133 genes were expressed at a higher level in 264 
CD1- cDC while 263 genes were expressed at a higher level in the CD1+ cDC 265 
(Supplementary Table S1). Of the 263 genes up-regulated in CD1+ cDC, 7 266 
genes had been previously reported to be upregulated in the cDC2 subset in 267 
other species (Table 1).  These were genes encoding C-type lectins CD206 268 
(MRC1) and CD302 (CLEC13A/DCL-1); TLR-1, -4 and -5; IL-10 and the IFN-269 
stimulated gene IFIT3 (Table 1).  Furthermore, 10 genes up-regulated in CD1- 270 
cDC- were also highly expressed in cDC1s from other species. The majority of 271 
these genes encoded membrane proteins (XCR1, CLEC12a, CD36, CD59, 272 
ANPEP and SEMA4f) although genes expressing cytosolic (PLEKHA5, 273 
FKBP1b-like and OXCT1) and secreted proteins (MMP9) were also identified 274 
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(Table 1). Analysis of the genes for the nine TLRs showed evidence of 275 
increased expression of TLR-3, -7, -8 and -9 in the CD1- DC population 276 
(although this was not found to be statistically significant) and an increased 277 
expression of TLR-1, -2, -4 and -5 in the CD1+ DC population (Supplementary 278 
Table S2).  These expression data are consistent with the observed 279 
stimulation of the same cDC populations with poly(I:C) (TLR3), CpG (TLR9) 280 
(both CD1- cDC) and LPS (TLR4) (CD1+ cDC) as shown in Figure 4.  281 
Finally, gene set enrichment analysis (GSEA) was employed to 282 
compare the transcriptomic signatures of the porcine CD1- and CD1+ cDC 283 
populations with publically available data sets corresponding to the human 284 
CD141+ and CD1c+ and mouse CD8α+ and CD11b+ populations (Table 2; See 285 
Supplementary Figure S3 and S4 for CD1- and CD1+ cDC enrichment plots, 286 
respectively, and Supplementary Table S3 for the human and murine datasets 287 
analysed).  Monocytes were selected as a reference population due to their 288 
shared myeloid lineage with DC and their orthology across species57. The 289 
porcine blood CD1- cDC transcriptomic signature was enriched in mouse 290 
cDC1 (ES=0.50, FDR=0.299) and statistically a significantly enriched in 291 
human cDC1 (ES=0.46, FDR=0.002), when compared to classical monocytes 292 
(cMo) from the same species. Similarly, the porcine blood CD1+ cDC 293 
transcriptomic signature was significantly enriched in both mouse cDC2 294 
(ES=0.53, FDR=0.013) and also, to a greater extent, in human cDC2 295 
(ES=0.49, FDR=0.005). Conversely, the porcine blood CD14+ monocyte 296 
signatures were enriched in the human and mouse cMo when compared to 297 
cDC1 or cDC2.  298 
 299 
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Discussion 300 
This study has provided a phenotypic and functional analysis of cDC from 301 
porcine blood. To the best of our knowledge, this study is the first to have 302 
rigorously isolated and studied porcine blood cDC2, and to have characterized 303 
them at the transcriptomic and functional levels. The notion that CD1 304 
expression may define distinct subsets was supported by the differential 305 
expression of CD1c by human blood cDC2. The complement receptor 306 
CD11R3 served as a second discriminatory marker since it was expressed 307 
only by CD1+ cDC. Notably CD11R3 is described as the orthologue for CD11b 308 
43, which is expressed on the mouse cDC2. CD1+ cDC were also found to 309 
express higher levels of CD172a, previously reported in murine, ovine and 310 
human cDC2 33.  Lower levels of CD172a were expressed on CD1- cDC 311 
population. This is in contrast to claims that cDC1 DC populations lack 312 
expression of CD172a35,58. This disparity is most likely due to the fact that 313 
these cells were isolated from blood as opposed to tissues. This is supported 314 
by the report of low expression of CD172a on cDC1 in human blood59.   315 
Comparison of the porcine blood DC phenotypes with DC isolated from 316 
other tissues was beyond the scope of the present study although some 317 
comparisons with previously published reports can be made. Others have 318 
previously demonstrated that DC populations in skin and draining afferent 319 
lymph and the lung could be defined by expression of CD172a and 320 
CD16335,37. Transcriptomic and functional studies demonstrated that the 321 
CD163low population expressed high levels of CD172a, were XCR1 negative, 322 
and shared gene expression with cDC2 suggesting they are the tissue 323 
resident equivalents of the CD1+ subpopulation described here.  Likewise, the 324 
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CD172a- cells were the only population to express XCR1, therefore likely to 325 
resemble the cDC1 population described in human and mouse and the CD1- 326 
population described here36,37.       327 
The functional analyses further support an organised specialisation 328 
between the populations. The CD1- cDC responded to PAMPs representing 329 
pathogen nucleic acids, poly(I:C) and CpG stimulating TLR 3 and 9 330 
respectively with secretion of IFN-α and IL-12.  In contrast, CD1+ cDC 331 
primarily responded to LPS stimulating TLR 4, with secretion of IL-10 and IL-332 
8.  These data suggest that CD1- cDC are programmed to drive type 1 T cell 333 
responses to control intracellular pathogens whereas CD1+ cDC drive type 2 T 334 
cell responses and support antibody responses to extracellular pathogens. 335 
The differential expression of IL-12 and IL-10 implies that the populations may 336 
also have a direct and opposing influence on one another. Like CD1- cDC, 337 
human CD141+ cDC were also found to be a prominent source of IL-12 and 338 
IFN-α after stimulation via TLR 360.  Similarly, in the mouse, higher levels of 339 
IL-12 and IFN-α were associated with CD8α+ cDC1s following stimulation via 340 
TLR 3 and 9 relative to CD11b+ cDC2s 8,10. Consistent with the CD1+ cDC2 341 
responses observed, CD1c+ cDC express TLR4 29 and secrete IL-10, but not 342 
IL-12, in response to E. coli 61.  The microarray data also demonstrated 343 
increased expression of TLR4 together with TLR1, TLR2, and TLR5 on CD1+ 344 
DCs. There was a marginal increase in TLR3 and 9 on the CD1- DCs as 345 
shown previously in mouse 8 (not statistically significant).  Notably, in the 346 
equivalent human blood CD141+ DCs, there was no expression of TLR9  29 .      347 
Our studies demonstrate that CD1+ cDC were able to take up soluble antigen 348 
most effectively which is consistent with the increased rates of antigen uptake 349 
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reported in vivo by mouse CD11b+ cDC2 DC localised in the splenic marginal 350 
zone compared to other splenic DC 62.  However, more recently it has been 351 
shown that mouse and human DC subsets demonstrate a similar capacity to 352 
take up soluble and particulate antigen29,51.  Collectively, these data suggest 353 
that an ability to take up antigen is not a reliable way of delineating cDC 354 
subsets. The superior ability of CD1- cDC to stimulate allogeneic T cells is in 355 
line with the corresponding ovine CD26+ cDC subset33.  CD1- cDC were also 356 
superior in their ability to cross-present viral antigen to CD8+ T cells which is a 357 
hall mark of CD8α+ DC  function 51,63 although this was only observed when 358 
cells were pulsed with whole virus and not when a synthetic 28mer peptide 359 
was applied. It is possible that the limited processing requirements of the 360 
peptide reduced the cellular requirements for cross-presentation. Overall, 361 
these functional studies provide evidence of orthology between cDC 362 
populations of humans, mice, sheep and pigs. GSEA analysis showed a 363 
conserved transcriptome signature between the pig CD1- and CD1+ cDC 364 
populations and publically available mouse splenic CD8α+ and CD11b+ cDCs 365 
and human CD141+ and CD1c+ populations.  That these subpopulations of 366 
cDC share a common genetic signature has been reported previously in 367 
sheep, mouse and human 24,33,50,55,64,65  A recent study confirmed orthology 368 
between the blood cDC1 population in pig with mouse and human 369 
equivalents, although the authors were unable to make any claims on the 370 
cDC2 population56. In this study, cDC1 were identified based on CADM1 371 
expression 27 rather than an absence of CD1 expression as employed here.  372 
Our preliminary assessment of CADM1 expression on DC subsets showed 373 
that whilst CADM1 expression was highest on CD1- cDC it was not uniformly 374 
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so (Supplementary Figure S5).  A more recent study reported the use of 375 
fluorescently-labelled recombinant XCL1 to identify cDC1 in porcine blood 66 .  376 
Given that XCR1 is an exclusive marker for the cDC1 population across 377 
species, we sought to establish the expression of XCR1 by the CADM1negative, 378 
CADM1dim and CADM1high cells which constituted the CD1- cDC population 379 
(Supplementary Figure S5).  Using monocytes as a reference population, RT-380 
qPCR demonstrated negligible levels of XCR1 on CD1+ DCs while relatively 381 
high levels were expressed on the CADM1high cells. Interestingly, XCR1, was 382 
also detected on the CADM1negative and CADM1dim cells albeit at a lower level 383 
than observed on the CADM1high cells, in contrast to FLT3 which was 384 
expressed at similar levels. It may be hypothesised that the diverse 385 
expression of CADM1 and XCR1 on CD1- cDC reflects a heterogeneous 386 
population of cDC1 at differing stages of maturation.  387 
In summary, this study has demonstrated the existence of two 388 
functionally distinct cDC subsets in pig blood that are aligned with the existing 389 
definition of DC populations by the IUIS and current understanding of cDC 390 
populations in other mammalian species. The ability to readily enrich these 391 
cell populations from peripheral blood provides a new model system to 392 
investigate DC plasticity and interactions with pathogens, including a number 393 
of important myelotropic viruses, and vaccines.  394 
 395 
Methods 396 
Animals 397 
All animal work was approved by the Animal and Plant Health Agency 398 
Ethics Committee and all procedures were conducted in accordance with the 399 
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UK Animals (Scientific Procedures) Act 1986 under Project Licences PPL 400 
70/7057 and 70/7209. Blood samples were collected from healthy Large 401 
White/Landrace cross-bred pigs, 6-24 months of age, by venopuncture of the 402 
external jugular vein. In selected experiments, blood was collected from pigs 403 
rendered immune to porcine reproductive and respiratory syndrome virus 404 
(PRRSV) by repeated intranasal inoculation with the attenuated genotype 1 405 
PRRSV strain Olot/9152. 406 
  407 
Dendritic cell and monocyte isolation from porcine blood  408 
PBMC were isolated from 200-500ml of heparinised blood by density 409 
gradient centrifugation as previously described67. PBMCs were suspended  in 410 
Dulbecco’s PBS without Mg2+ and Ca2+ (Life Technologies, Paisley, UK) 411 
supplemented with 2% FBS (Autogen Bioclear, Calne, UK)  (PBS/2%FBS) 412 
and counted using a volumetric flow cytometer (MACSQuant Analyzer, 413 
Miltenyi Biotec, Bisley, UK). To deplete/isolate monocytes, PBMC were 414 
incubated with mouse anti-human CD14 microbeads (IgG2a; 10µl/107 cells; 415 
Miltenyi Biotec) for 15 min at 4oC, washed twice (520g for 10 min) passed 416 
through a 100µm cell strainer (BD Biosciences, Oxford, UK), and applied to 417 
pre-equilibrated LD columns as indicated by the manufacturer (Miltenyi 418 
Biotec). The CD14+ cells were purged from the LD column in 3ml of PBS/2% 419 
FBS with 2mM EDTA (MACS buffer) and applied to an LS column. 420 
Essentially, DC were enriched using methods similar to those described 421 
previously68. Briefly, 10μg/108 cells of anti-porcine CD172a mAb (IgG2b, clone 422 
74-22-15A, Washington State University Monoclonal Antibody Center 423 
(WSUMAC), Pullman, USA) was added to the CD14 depleted fraction of cells 424 
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for 30 minutes at 4oC. After washing, cells were incubated with anti-mouse 425 
IgG microbeads (10µl/107 cells, Miltenyi Biotec) as described above and 426 
CD172a+ cells were isolated by applying the cells to an LS column (Miltenyi 427 
Biotec).  Both CD172a+ and CD14+ cells were purged from the LS columns in 428 
5ml of MACS buffer and counted as above. To enable flow cytometric sorting 429 
of DC subsets from the CD14-CD172a+ enriched population, cells were 430 
stained with IgG1 mAbs directed to lineage (lin) markers (CD14, clone 431 
CAM36A, WSUMAC; CD3, clone 8E6, WSUMAC; CD8α, clone PT3613, 432 
WSUMAC; and CD21, clone B-Ly4, BD Biosciences), CD14, CD3 and CD8 433 
mAbs were applied at a final concentration of 20μg/108 cells and CD21 mAb 434 
was used at 10μg/108 cells.  After 30 min incubation at 4oC, cells were washed 435 
and stained with PE-conjugated rat anti-mouse IgG1 secondary antibody (BD 436 
Biosciences). After washing, cells were stained with CD172a mAb conjugated 437 
to Alexa Fluor-647® using the APEX™ Antibody Labelling Kit (Life 438 
Technologies) (10μg/107 cells), CD1-FITC mAb (2.5μg/107cells; clone 76-7-4, 439 
Southern Biotec, Cambridge Bioscience, Cambridge, UK) and CD4-PerCP™-440 
Cy5.5 mAb (0.4μg/107cells, clone 74-12-4, BD Biosciences). In addition, 441 
2.5x105 cells were stained with each mAb individually to serve as single 442 
colour compensation controls. Cells were washed, suspended in RPMI-1640 443 
medium supplemented with 10% FBS at 1x107 cells/ml and sorted using a 444 
MoFlo® Astrios™ Cell Sorter (Beckman Coulter, High Wycombe, UK). DC 445 
were gated as singlet, CD172a+lin- cells, and sorted into CD1-CD4- cDC, 446 
CD1+CD4- cDC and CD1-CD4+ pDC populations. Any contaminating 447 
monocytes were excluded by gating out CD172ahi events and lineage positive 448 
cells.  Immediately after sorting, the cells were checked for purity and counted 449 
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by flow cytometric analysis on a MACSQuant Analyzer (Miltenyi Biotec). To 450 
assess DC subsets without prior enrichment PBMC were stained with the 451 
monoclonal antibodies as described above but with the inclusion of CD14 PE-452 
Texas Red (clone Tük 4; Life Technologies) and analysed using a BD 453 
Fortessa flow cytometer (BD Biosciences).    454 
 455 
Flow cytometric analysis of porcine blood DC subsets and monocytes   456 
The sorted DC subsets and monocytes  were seeded at 5x104/well and 457 
stained with 10µl of porcine MHC class II-DR (IgG1, clone 2E9/13), CD11R3 458 
(CD11b-like; IgG1 clone 2F4/11), CD16 (IgG1, clone G7) mAbs (all Bio-Rad, 459 
Oxford, UK) and huCD152-muIg fusion protein (IgG2a, Enzo Life Sciences, 460 
Exeter, UK) conjugated to R-PE using Zenon® Mouse IgG Labelling Kits (Life 461 
Technologies), and with biotinylated polyclonal anti-huCD83 antibody (R&D 462 
Systems, Abingdon, UK). Non-reactive antibodies matched by host and 463 
isotype were included at equivalent concentrations as controls. After 30 min at 464 
4oC the cells were washed twice with 200µl/well of PBS/2% FBS and 465 
centrifuged as above. In the case of biotinylated CD83 antibody, streptavidin-466 
PE (eBioscience, Hatfield, UK) was added (50ng/well) and incubated for a 467 
further 20 min at 4oC.  All wells were washed twice and then cells were fixed 468 
by addition of 200μl of CellFIX (BD Biosciences) and a minimum of 2.5x104 469 
cells were analysed on a MACSQuant Analyzer flow cytometer.  To assess 470 
CADM1 expression, CD14 depleted, CD172a enriched cells were labelled as 471 
described above with the addition of anti-CADM1 mAb (clone 3E1, Caltag 472 
Medsystems, Buckingham, UK)  and then detected with biotinylated anti-473 
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chicken IgY antibody(Stratech Scientific, New Market, UK) followed by 474 
streptavidin-Brilliant Violet 605 (BioLegend, London UK).      475 
 476 
Assessment of cytokine responses to TLR agonists  477 
TLR agonists were diluted in cRPMI; LPS from E. coli K12, high-478 
molecular weight polyinosinic-polycytidylic acid (poly(I:C)) (both 20µg/ml) and 479 
class B CpG oligonucleotide ODN2007 (10µM) (all from Invivogen, Source 480 
Biosource, Nottingham, UK) and applied to DC and monocytes seeded at 481 
5x104/well in triplicate wells. To serve as a negative control, 100μl of cRPMI 482 
was added to an additional three wells. Recombinant porcine IL-3 was added 483 
at a final concentration of 10ng/ml to all wells containing pDC in these and 484 
subsequent experiments. Following incubation for 18 h at 37oC in a humidified 485 
5% CO2 atmosphere, cell-free culture supernatants were removed and stored 486 
immediately at -80oC for subsequent cytokine analysis. Culture supernatants 487 
were assessed for cytokine content using the Porcine Cytokine 1 Ciraplex™ 488 
Chemiluminescent Assay Kit (Aushon, Billerica, USA) and IL-12 ELISA 489 
(Porcine IL-12/IL-23 p40 DuoSet; R&D Systems, Abingdon, UK) according to 490 
the manufacturers’ instructions.  491 
 492 
Mixed leukocyte reaction 493 
Sorted blood DC subsets and monocytes were adjusted to 2.5x105 494 
cells/ml in cRPMI and a three-fold dilution series of each population was 495 
prepared. Allogeneic PBMCs were added (5x105 cells/well) at responder to 496 
stimulator cell ratios ranging from 2:1 to 162:1. Pokeweed mitogen (Sigma, 497 
Poole, UK) and cRPMI were added to wells containing only PBMC as positive 498 
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and negative controls, respectively.  After 72 h incubation at 37oC in a 499 
humidified 5% CO2 atmosphere, cells were pulsed with 1μCi/well 3H-thymidine 500 
(GE Healthcare, Little Chalfont, UK) and incubated for a further 24 h. Cells 501 
were harvested onto filter mats using a Harvester 96 Mach III (TomTec Inc, 502 
Hamden, USA) and 3H-thymidine incorporation measured by addition of 503 
25μl/well Microscint O and counting on a MicroBeta2 Plate Counter (both 504 
Perkin Elmer, High Wycombe, UK).  505 
 506 
Endocytosis/phagocytosis assay 507 
Enriched blood DC or sorted monocytes were suspended in cRPMI and 508 
seeded at 5x104 cells/well in round-bottom 96-well plates. Cells were pulsed 509 
with either 1.25μg/well particulate antigen in the form of Alexa Fluor-647®-510 
conjugated ovalbumin (Life Technologies) encapsulated in PLGA-511 
nanoparticles69, or 2μg/well of soluble Alexa Fluor-647®-conjugated ovalbumin 512 
(Life Technologies) to investigate phagocytosis and endocytosis, respectively. 513 
Cells were incubated at either 4oC or 37oC for 2 h, washed twice to remove 514 
free antigen, stained with CD1-FITC and CD4-PerCP-Cy5.5 mAb to 515 
discriminate DC subsets and uptake analysed by flow cytometry.        516 
 517 
  518 
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Antigen processing and presentation assay 519 
Blood DC subsets and monocytes were sorted from two PRRSV 520 
immune pigs and 1x105 cells were pulsed in triplicate with 1μg/ml synthetic 521 
28mer peptide bearing previously identified CD4 and CD8 T cell epitopes from 522 
PRRSV 52  or 105 TCID50 equivalent dose of heat-inactivated (56oC, 1hr) 523 
PRRSV-1 Olot/91 strain. cRPMI or an equal volume of clarified cryolysate of 524 
MARC-145 cells (mock virus antigen) was added as a negative control for 525 
peptide and virus stimulations, respectively. Following an incubation at 37oC 526 
for 2 h, cells were washed twice as above, and DC/monocyte depleted 527 
autologous PBMC (5x105 cells/well) and GolgiPlug, (0.2μl/well; BD 528 
Biosciences) were added to each well. Cells were then incubated 37oC for a 529 
further 18 h before assessment of CD4+ and CD8+ T cell IFN-γ responses by 530 
flow cytometric analysis as previously described 67 .  531 
Gene expression microarray analysis  532 
All kits were used according to the manufacturer’s instructions. Sorted 533 
blood DC subsets and monocytes were washed in cRPMI and 0.5-1x106 cells 534 
collected by centrifugation (900g, 3min). The supernatants were removed and 535 
cells snap-frozen in liquid nitrogen and stored at -80oC until RNA was 536 
extracted using an RNAqueous micro Kit (Life Technologies). The Ovation 537 
PicoSL WTA System v2 kit (NuGEN, Leek, The Netherlands) was used to 538 
amplify cDNA from 50ng total RNA. The MinElute Reaction Cleanup Kit 539 
(Qiagen) was used to purify cDNA, and 1μg was then labelled using a one-540 
color DNA labelling kit (NimbleGen, Madison, USA). For each sample, 4μg 541 
labelled cDNA was hybridised to a custom NimbleGen 12x135K porcine array 542 
designed using the Sus scrofa 10.2 genome build and incorporating a total of 543 
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19,351 genes, each represented on the array by a set of six different probes 544 
(116,106 probes in total). The microarray also contains a large number 545 
(24,179) of random probes. Hybridised arrays were scanned at 2μm 546 
resolution on a microarray scanner (Agilent, Wokingham, UK). Microarray 547 
images were processed using DEVA v1.2.1 software to obtain a pair report 548 
containing the signal intensity values for each probe. The raw intensity values 549 
were corrected for background by subtracting the median intensity values of 550 
the 20 nearest neighbour random probes.  To correct for differences in the 551 
overall intensity levels between slides robust multi-array normalisation was 552 
used. From this point, the expression analysis was assessed at probe level as 553 
well as gene level. At the probe level, differential probe intensity between any 554 
two given cell types were identified using the Limma package70 with the p-555 
values adjusted for multiple testing using the Benjamini and Hochberg’s 556 
method. Using the normalised probe intensity data matrix, the two first 557 
principal components (65.5% of the cumulative variability in the data set) were 558 
used to visualise the overall gene expression relationship between the 559 
samples 71 The PCA analysis showed an acceptable agreement between the 560 
biological replicates and also a significant segregation between the sample 561 
conditions (Figure 6). To calculate the gene expression level, the median 562 
polish algorithm was applied to the normalised probe intensity data matrix 72. 563 
Differential gene expression tables were completed with information on the 564 
corresponding probes intensities; the number of probes with an adjusted p-565 
value < 0.05 (as significant), 0.05-0.1 (as low significance) and >0.1 (as non-566 
significant). When comparing gene expression between two cell types, a gene 567 
was considered for further analysis if: (1) at the gene-level, it showed a 568 
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significant difference (adjusted p-value < 0.05) between cell types, (2) at the 569 
gene-level, the difference of expression between cell types was greater than 570 
2-fold and (3) at the probe-level, no less than 4 of the probes showed 571 
significant differences between cell types. The raw microarray data 572 
(background-corrected signal) can be assessed at Gene Expression Omnibus 573 
(GEO accession GSE84029; GEO reviewer link: 574 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ovyteeqivfeftqd&acc=G575 
SE84029). 576 
Pairwise gene set enrichment analysis for cross-species comparison of 577 
porcine blood cDC subsets 578 
To assess the orthology of the transcriptome of the porcine cDC populations 579 
with published datasets from equivalent human and murine cDC populations, 580 
Gene Set Enrichment Analysis (GSEA) was applied73. The published human 581 
and murine cDC transcriptomic datasets were obtained from Gene Expression 582 
Omnibus (GEO) accessions GSE35459 and GSE15907, respectively (see 583 
Supplementary Table S3 for further details regarding the human and murine 584 
datasets analysed).  The GSEA-P package was employed. As input gene 585 
sets, we generated the up- and down-regulated gene transcriptomic 586 
signatures of porcine blood CD1- cDC or CD1+ cDC when compared to CD14+ 587 
monocytes. We then examined whether these transcriptomic signatures/gene 588 
sets were significantly enriched in the corresponding human or mouse cell 589 
type using pairwise comparisons between cDC1 or cDC2 versus CD14+ 590 
monocytes in each species. To generate the ranked gene lists for these 591 
species, the GSEA-P package was employed based on the entire data sets. 592 
The enrichment scores (ES) and their statistical significance (p) were 593 
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calculated for the gene sets in each of the cell population comparisons. The 594 
risk of false positive enrichment was estimated using the false discovery rate 595 
(FDR, q) calculated upon performing 1,000 random permutations of classes73.  596 
 597 
Additional data analysis and statistics.  598 
Graphical and statistical analysis of non-array data was performed 599 
using GraphPad Prism 6 (GraphPad Software Inc, La Jolla, USA). Data was 600 
represented as means with standard errors (SEM). A two tailed unpaired t-test 601 
or a one-way analysis of variance (ANOVA) followed by Dunnett’s test was 602 
used and a p-value < 0.05 was considered statistically significant.  603 
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Figure Legends 904 
Figure 1: Sorting strategy for the isolation of porcine blood DC populations.  905 
Blood DC, enriched by magnetic depletion of CD14+ cells and selection of 906 
CD172a+ cells, were stained with mAbs to CD172a and lineage markers (lin; 907 
CD3, CD8α, CD21) (A).  Large (gate 1) CD172a+lin- (gate 2) blood DC 908 
subsets were then sorted on expression CD1 and CD4: CD4-CD1- cDC (gate 909 
3), CD4-CD1+ cDC (gate 4) and CD1-CD4+ pDC (gate 5). Sorted blood DC 910 
subsets showed >95% purity when assessed by flow cytometry (B).  911 
 912 
Figure 2: Sorted porcine blood DC populations and monocytes express 913 
distinct cell surface phenotypes. Freshly isolated monocytes, CD1- cDC, CD1+ 914 
cDC and pDC were stained with a panel of DC markers (black histograms) 915 
and corresponding host/isotype matched control antibodies (grey histograms) 916 
and analysed by flow cytometry. Representative data is shown from 1 of 3 917 
individual pigs analysed.  918 
 919 
Figure 3:  Assessment of the effect of cell culture on the phenotype of sorted 920 
porcine blood DC populations and monocytes. Expression of MHC class II DR 921 
and CD80/86 by monocytes, CD1- cDC, CD1+ cDC and pDC upon isolation 922 
(fresh) or following an 18 h culture (cultured) was assessed by flow cytometry. 923 
MHC class II DR and CD80/86 staining (black histograms) was compared 924 
against the corresponding isotype control antibody (grey histograms) and 925 
representative data is shown from 1 of 3 individual pigs analysed.  926 
 927 
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Figure 4: Differential responses of sorted porcine blood DC populations and 928 
monocytes to PAMP stimulation. Monocytes, CD1- cDC, CD1+ cDC and pDC 929 
were cultured in the presence of poly(I:C), LPS, CpG-ODN 2007 or in medium 930 
alone for 18 h. Cytokine content of cell-free culture supernatants were then 931 
assessed by multiplex (TNF-α, IFN-γ, IFN-α, IL-10 and IL-8) or singleplex (IL-932 
12) ELISAs and data presented as the mean cytokine concentration of 933 
triplicate pooled supernatants from 3 pigs ± SEM. 934 
  935 
Figure 5: Assessment of the antigen uptake, processing and presentation 936 
capabilities of porcine blood DC populations and monocytes. The ability of 937 
blood DC populations and monocytes to endocytose soluble and phagocytose 938 
particulate antigen was examined using Alexa Fluor-647®-conjugated 939 
ovalbumin either in soluble form or encapsulated in PLGA nanoparticles. 940 
Antigen uptake was determined after 1 h by flow cytometry. Antigen uptake 941 
was measured by mean fluorescence intensity measurements and data 942 
presented are the mean 4oC corrected antigen uptake at 37oC for triplicate 943 
cultures from 1/3 representative experiments (A).  Stimulation of antigen-944 
specific CD4+ and CD8+ T cell IFN-γ responses by sorted blood DC 945 
populations and monocytes pulsed with a 28mer synthetic peptide carrying 946 
defined CD4 and CD8 T cell epitopes (long peptide) or inactivated PRRSV 947 
was assessed by flow cytometry. The unstimulated or, in the case of PRRSV, 948 
the mock-virus stimulated corrected mean % IFN-γ+ live, singlet CD8 (CD4-949 
CD8αhigh; left y-axis) and memory CD4 (CD4+CD8αlow; right y-axis) T cells for 950 
triplicate cultures from 1 of 2 experiments are presented (B). Allogeneic T cell 951 
stimulatory capacity of monocytes and DC populations was assessed in a 952 
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mixed-leukocyte reaction and lymphoproliferation assessed by 3H-thymidine 953 
incorporation. The data are presented as the mean incorporated counts per 954 
minute (cpm) of triplicate cultures ± SEM from 1 of 2 experiments (C). For all 955 
plots error bars represent SEM. Values were compared using a two-tailed un-956 
paired t-test and significance indicated by ***p<0.001, **p<0.01, *p<0.05. 957 
 958 
Figure 6:  Gene expression profiling of porcine blood DC and monocytes. 959 
Principle component analysis (PCA) analysis of the isolated cell populations 960 
Monocytes (black), pDC (red), CD1+ cDC (blue) and CD1- cDC (green) 961 
clusters showing two principle components representing 65.6% of total gene 962 
variation. Data for sorted blood DCs subsets and monocytes from three pigs 963 
are presented. 964 
 965 
 966 
 967 
 968 
969 
 36 
 
Table 1. Differential gene expression in porcine blood cDC populations with 970 
orthology in other species  971 
 972 
Porcine 
cDC 
population 
Gene name 
Fold 
change a 
P-value 
Human, murine or ovine DC subset 
b 
CD1+ MRC1 12.2 0.015 HuCD1c  50 
CD1+ TLR5 6.44 0.026 MuCD11b, HuCD1c 24 
CD1+ TLR4 6.33 0.075 HuCD1c 61 
CD1+ CD302 4.77 0.017 MuCD11b, HuCD1c 24 
CD1+ IFIT3 3.74 0.028 MuCD11b, HuCD1c 24 
CD1+ TLR1 3.44 0.021 MuCD11b, HuCD1c 24 
CD1+ IL-10 3.05 0.05 HuCD1c 61 
CD1- XCR1 29.81 0.025 HuCD141, MuCD8α, OvCD26 33,55 
CD1- ANPEP 23.3 0.023 HuCD141, MuCD8α, OvCD26 33 
CD1- CD59 18.82 0.078 HuCD1c 65 
CD1- MMP9 14.01 0.06 HuCD141 74 
CD1- PLEKHA5 8.73 0.021 HuCD141, MuCD8α 24 
CD1- SEM4f 8.66 0.014 HuCD141, MuCD8α 24 
CD1- S100-z-like 8.62 0.058 MuCD8α 8 
CD1- CD36 7.86 0.116 MuCD8α 25 
CD1- IL12RB2 4.56 0.027 MuCD8α 33 
CD1- ADAMDEC1 4.25 0.048 MuCD8α 8 
CD1- CLEC12a 3.52 0.025 MuCD8α64 
CD1- FKBP11-like 3.02 0.012 HuCD141, MuCD8α 24 
CD1- OXCT1 2.60 0.035 MuCD8α 8 
a Expression fold-change CD1+ vs. CD1- cDC displayed as absolute values 973 
b Genes whose expression has previously been reported to be associate with 974 
cDC subsets in mice, humans or sheep. 975 
976 
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Table 2.  Summary of the gene-set enrichment analysis of porcine blood cDC 977 
transcriptomes versus orthologous human and mouse cDC subsets 978 
Porcine 
blood 
cell type 
Gene 
sets 
Pairwise 
comparisons 
between 
mouse or 
human cell 
types 
 
 
Enriched 
in 
Enrichment 
Score (ES) 
a 
P - 
value b 
False 
Discovery 
Rate (q) b 
CD1- vs 
CD14+ 
up 
Human cDC1 
vs  CD14+ 
cMo 
cDC1 
0.46 0 0.002 
CD1- vs 
CD14+ 
up 
Mouse cDC1 
vs Ly6c+ cMo 
cDC1 
0.50 0.171 0.299 
CD1- vs 
CD14+ 
down 
Human cDC1 
vs  CD14+ 
cMo 
cMo c 
-0.67 0.005 0.007 
CD1- vs 
CD14+ 
down 
Mouse cDC1 
vs Ly6c+ cMo 
cMo 
-0.59 0.113 0.266 
CD1+ vs 
CD14+ 
up 
Human cDC2 
vs CD14+ 
cMo 
cDC2 
0.49 0.003 0.005 
CD1+ vs 
CD14+ 
up 
Mouse cDC2 
vs  Ly6c+ cMo  
cDC2 
0.53 0.021 0.013 
CD1+ vs 
CD14+ 
down 
Human cDC2 
vs CD14+ 
cMo 
cMo 
-0.64 0 0.002 
CD1+ vs 
CD14+ 
down 
Mouse cDC2 
vs  Ly6c+ cMo  
cMo 
-0.55 0.025 0.057 
 979 
a The ES is calculated out of a possible maximum of 1 and minimum of -1.  980 
b Values of p ≤0.1 and q ≤0.25 are considered to indicate significant 981 
enrichment. 982 
c Classical monocytes. 983 
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